Financials
Financial year 2025
Ap. Pharmamax from Boom, company number BE0434458941, closed financial year 2025 with a result of € 130,718 after tax. For that financial year Ap. Pharmamax recorded a gross margin of € 184,049 and equity of € 377,746. Compared with financial year 2024, the result moved from € 290,195 to € 130,718. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.
€ 377,746
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 130,718
▼ 55% vs 2024
Profit after tax over the fiscal year.
€ 549,619
▲ 55% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 103,000 paid out
79 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
▼ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 155,275
▲ 123% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,501
▲ 5% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 361,245 | € 368,428 | € 353,399 | € 184,049 | ▼ 48% |
| Profit after taxes | € 222,358 | € 323,030 | € 290,195 | € 130,718 | ▼ 55% |
| Equity | € 326,803 | € 349,833 | € 350,028 | € 377,746 | ▲ 8% |
| Total debts | € 246,103 | € 501,968 | € 660,063 | € 707,463 | ▲ 7% |
| Cash | € 232,530 | € 343,526 | € 355,528 | € 549,619 | ▲ 55% |
| Land & buildings | € 59,915 | € 51,771 | € 45,266 | € 38,761 | ▼ 14% |
| Retained profit | € 301,803 | € 324,833 | € 325,028 | € 352,746 | ▲ 9% |
| Dividend | € 0 | € 300,000 | € 290,000 | € 103,000 | ▼ 64% |
| Bank debt | € 27,851 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 572,906 | € 851,801 | € 1,010,091 | € 1,085,209 | ▲ 7% |
| Employees (FTE) | 0 | 0.8 | 0.8 | 0 | ▼ 0.8 |
Key figures of Ap. Pharmamax, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Ap. Pharmamax?
What happened at Ap. Pharmamax in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 130,718 (▼ 55% vs 2024). filed late Source: NBB ↗
- Pharmagrex NV became a director. NBB
- New establishment in Boom. KBO
- Start of the company according to the CBE. KBO
In short
From € 222,358 profit in 2022 to € 130,718 profit in 2025.
Paid € 110,345 in corporate taxes since 2022.
Best year ever: 2023, with € 323,030 profit.
Paid out € 693,000 in dividends to the owners in total.
Management
Behind Ap. Pharmamax is Pharmagrex NV.
Directors
According to the 2025 annual accounts
Director · represented by Martine Bleys
since 2015
Establishments
Establishment units
Physical locations of this company
Peter Benoitstraat 46
2850 Boom
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0434.458.941
- VAT number
- BE 0434.458.941
- Registered office
- Peter Benoitstraat 46, 2850 Boom
- Names & denominations
- Ap. Pharmamax
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 June 1988
- Peppol
- Active · Active since 3 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers